Edited by Girish N. Vyas; Herbert A. Perkins; and Rudi Schmid. Price, $15. Pp 428. Grune & Stratton, Inc., 111 Fifth Ave, New York 10003, 1972.
This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
A symposium organized in connection with the meeting of the contract investigators of the National Blood Resource Branch of the National Heart and Lung Institute brought together leading investigators to the University of California Medical Center in San Francisco. The proceedings of the meeting took place on March 25 and 26, 1972 and form the basis for this monograph.
Because viral hepatitis continues to be a major public health problem, and transfusion therapy presents so many enigmas, an updated symposium was consummated. Over 100 contributors participated. Robert Q. Marston wrote in his introductory remarks, "The problem of viral hepatitis is closely linked to the need for an adequate and safe supply of blood and blood components for transfusion."
The essayists begin with a definition of terminology that suggested that the term "HAV" would refer to the hepatitis A virus, "HBV" signified the hepatitis B virus, "HBag" referred to the hepatitis
DeLor CJ. Hepatitis and Blood Transfusion. Arch Intern Med. 1973;132(6):914. doi:10.1001/archinte.1973.03650120112030
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: